Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer’s Disease
Amyloid-β peptide (Aβ) is still best known as a molecule to cause Alzheimer’s disease (AD) through accumulation and deposition within the frontal cortex and hippocampus in the brain. Thus, strategies on developing AD drugs have been focused on the reduc-tion of Aβ in the brain. Since accumulation of...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Korean Society of Applied Pharmacology
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794520/ |